Cargando…
Plasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people
AIM: Based on its regulatory action on glucagon-like peptide 1, dipeptidyl peptidase IV (DPP-IV) has increasingly been linked to Type 2 diabetes. However, there is no evidence as to how this normal modulatory enzyme leads to pathology. It is thought that DPP-IV is affected by the development of obes...
Autores principales: | Neidert, Leslie E., Wainright, Katherine S., Zheng, Chen, Babu, Jeganathan Ramesh, Kluess, Heidi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946079/ https://www.ncbi.nlm.nih.gov/pubmed/27441271 http://dx.doi.org/10.1016/j.heliyon.2016.e00097 |
Ejemplares similares
-
Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats
por: Neidert, Leslie E., et al.
Publicado: (2018) -
Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020) -
Neuropeptide Y and dipeptidyl peptidase IV in normally cycling and postmenopausal women: A prospective pilot study
por: Kluess, Heidi A., et al.
Publicado: (2019) -
The serine protease, dipeptidyl peptidase IV as a myokine: dietary protein and exercise mimetics as a stimulus for transcription and release
por: Neidert, Leslie E., et al.
Publicado: (2016) -
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)